HISTAMINE-INDEPENDENT MAST CELL NERVE INTERACTIONS IN ALLERGY

过敏中不依赖组胺的肥大细胞神经相互作用

基本信息

  • 批准号:
    9272358
  • 负责人:
  • 金额:
    $ 38.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-05-12 至 2021-04-30
  • 项目状态:
    已结题

项目摘要

Itch is a primary symptom of many allergic conditions, and severely affects the quality of life and productivity. Primary sensory neurons residing in the trigeminal ganglia and dorsal root ganglia (DRG) play an essential role in the generation of allergic itch. These neurons detect endogenous itch-inducing molecules (pruritogens) via a group of itch receptors on their peripheral axons in the skin or mucosal membrane tissues, and transmit signals to the spinal cord via their central axons. In contrast to the well-studied histamine pathway, histamine-independent itch pathways in allergic itch remain poorly defined. Previously, we identified several novel itch receptors within a large family of G-protein‒coupled receptors called Mrgprs. We found that several Mrgprs recognize distinct pruritogens, and mediate histamine-independent itch. Our latest results indicate that Mrgprs are required for mast cell-mediated allergic itch. This proposal aims to uncover the underlying mechanisms. We will test whether Mrgprs mediate the interaction between mast cells and primary sensory fibers in allergic itch using molecular, genetic and imaging approaches in Aim 1. Furthermore, we will identify the endogenous Mrgpr ligands released by mast cells upon degranulation in Aim 2. In Aim 3, we seek to translate our discoveries from mice to humans. Human Mrgprs do not form clear orthologous pairs with mouse Mrgprs. Their role in itch is therefore unclear. Based on our preliminary data, we hypothesize that human MrgprX1 mediates neuronal and behavioral response to mast cell-mediated allergy, which will be tested in Aim 3. These studies will reveal the neural basis underlying allergic itch and will have a significant impact on both the study of itch pathogenesis and the clinical treatment of itch.
瘙痒是许多过敏性疾病的主要症状,严重影响生活质量, 生产力位于三叉神经节和背根神经节(DRG)的初级感觉神经元起着重要的作用。 在过敏性瘙痒的产生中起重要作用。这些神经元检测内源性瘙痒诱导分子 通过皮肤或粘膜组织中其外周轴突上的一组瘙痒受体, 并通过它们的中央轴突将信号传输到脊髓。与研究充分的组胺相反, 尽管组胺非依赖性瘙痒通路在过敏性瘙痒中的作用尚不明确。此前,我们发现 G蛋白偶联受体大家族中的几种新的瘙痒受体,称为Mrkidney。我们发现 几种Mrsal识别不同的致敏原,并介导组胺非依赖性瘙痒。我们的最新结果 表明肥大细胞介导过敏性瘙痒需要Mrs12。这项提案旨在揭示 基本机制。我们将测试Mrs12是否介导肥大细胞和原发性肥大细胞之间的相互作用。 过敏性瘙痒中的感觉纤维使用分子,遗传和成像方法在目的1中。此外,我们将 鉴定Aim 2中肥大细胞脱粒后释放的内源性Mrgpr配体。在目标3中,我们寻求 将我们的发现从小鼠转化为人类。人类的精子不能与 老鼠先生。因此,它们在瘙痒中的作用尚不清楚。根据我们的初步数据,我们假设, 人类MrgprX 1介导对肥大细胞介导的过敏的神经元和行为反应,这将进行测试 目标3。这些研究将揭示过敏性瘙痒的神经基础,并将对 无论是瘙痒发病机制的研究,还是瘙痒的临床治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Qin Liu其他文献

Qin Liu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Qin Liu', 18)}}的其他基金

Neural Circuits Controlling Lacrimation
控制流泪的神经回路
  • 批准号:
    10718512
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
CRISPR/Cas9-based gene editing approaches for the treatment of USH2A-associated diseases
基于 CRISPR/Cas9 的基因编辑方法用于治疗 USH2A 相关疾病
  • 批准号:
    10626831
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
CRISPR/Cas9-based gene editing approaches for the treatment of USH2A-associated diseases
基于 CRISPR/Cas9 的基因编辑方法用于治疗 USH2A 相关疾病
  • 批准号:
    10446571
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
The Neural Mechanism of Respiratory Allergies and Infections
呼吸道过敏和感染的神经机制
  • 批准号:
    10405559
  • 财政年份:
    2021
  • 资助金额:
    $ 38.13万
  • 项目类别:
The Neural Mechanism of Respiratory Allergies and Infections
呼吸道过敏和感染的神经机制
  • 批准号:
    10279722
  • 财政年份:
    2021
  • 资助金额:
    $ 38.13万
  • 项目类别:
The Neural Mechanism of Respiratory Allergies and Infections
呼吸道过敏和感染的神经机制
  • 批准号:
    10612424
  • 财政年份:
    2021
  • 资助金额:
    $ 38.13万
  • 项目类别:
HISTAMINE-INDEPENDENT MAST CELL NERVE INTERACTIONS IN ALLERGY
过敏中不依赖组胺的肥大细胞神经相互作用
  • 批准号:
    9160145
  • 财政年份:
    2016
  • 资助金额:
    $ 38.13万
  • 项目类别:
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
整合外周血生物标志物特征用于肺癌的诊断、预后、缓解和复发
  • 批准号:
    9904543
  • 财政年份:
    2016
  • 资助金额:
    $ 38.13万
  • 项目类别:
HISTAMINE-INDEPENDENT MAST CELL NERVE INTERACTIONS IN ALLERGY
过敏中不依赖组胺的肥大细胞神经相互作用
  • 批准号:
    9908041
  • 财政年份:
    2016
  • 资助金额:
    $ 38.13万
  • 项目类别:
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
整合外周血生物标志物特征用于肺癌的诊断、预后、缓解和复发
  • 批准号:
    10376913
  • 财政年份:
    2016
  • 资助金额:
    $ 38.13万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了